HDU critiques NIPRO needles in letter to FDA
Home Dialyzors United members know dialysis needles—they use them several times a week. The group challenged the “substantial equivalence” determination of NIPRO needles this month for a variety of reasons in a letter to the FDA. See the NIPRO response below.
Read the full article » | Posted 05-09-2015
Related Articles
- ACA Plan Premiums Could Skyrocket Posted 11-11-2025
- The Telehealth Coverage Act of 2025 H.R. 2263, Could Keep COVID Telehealth Rules Posted 11-11-2025
- Affordable Care Act’s Enhanced Premium Tax Credits (ePTC) End 12/31/2025 Posted 10-14-2025
- As of 10/1/2025, Medicare Stopped Paying for Most Telehealth Until Congress Acts Posted 10-14-2025

